YOUR PATIENTS’ CO-MORBIDITIES ARE CRITICAL PREDICTORS OF EARLY CV DISEASE.

YOUR PATIENTS’
CO-MORBIDITIES ARE CRITICAL PREDICTORS OF EARLY CV DISEASE.

IDENTIFY

Learn how the Cardiac Continuum can help identify the impact of comorbidities on CV health.

____________________________

CONFIRM

Quantify patient risk by measuring existing plaque with coronary artery calcium (CAC) scoring.

____________________________

MANAGE

Once at-risk patients have been identified, proactive management of their risk can improve CV outcomes.

LEARN MORE

Lorem ipsum dolor sit amet, consectetur adipisici elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquid ex ea commodi consequat. Quis aute iure reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint obcaecat cupiditat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

HELP KEEP PATIENTS’
HEARTS IN THE GAME—

with heart health educational tools on our website, including the Bayer^® Aspirin Heart Risk Assessment tool, a patient-facing quiz that can help you have a meaningful discussion with your patients about their cardiovascular (CV) risk factors.

LEARN ABOUT THE RISK ASSESSMENT TOOL

HEART ATTACK RISK
IS MORE RELEVANT THAN EVER

EVERY YEAR, MORE THAN 800,000 PEOPLE IN THE UNITED STATES HAVE A HEART ATTACK^²

HEART ATTACK AND STROKE RISK CAN INCREASE AFTER COVID—EVEN WITH A MILD CASE^³

germs glowing as if they are being viewed through night vision goggles

TAKE A LOOK AT HOW WE’RE HELPING RAISE CV RISK AWARENESS AMONG FANS

HEART HEALTH TOOLS & RESOURCES

References: 1. Data on file, Bayer. 2. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update. A report from the American Heart Association. Circulation. 2019;139(10):e56-e528. doi:10.1161/CIR.0000000000000659 3. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583-590. doi:10.1038/s41591-022-01689-3

ATTENTION